SGRY SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES SURGERY PARTNERS, INC.
PR Newswire•26/10/2026•14:26 ET
2
Key Highlights
- ➤Surgery Partners (SGRY) shareholders to receive $23.50 per share in cash
- ➤HealthSpan acquisition values Surgery Partners at approximately $5.7 billion enterprise value
- ➤Ademi LLP investigates whether the buyout price fairly reflects Surgery Partners’ value
- ➤Investigation examines insider change-of-control benefits and deal protections
- ➤Investigation questions restrictions on competing offers, including a significant termination penalty
Expert Statements
Guri Ademi, Attorney at Ademi LLP
“Ademi LLP is investigating whether the proposed acquisition of Surgery Partners (NYSE: SGRY) by HealthSpan, provides fair value to Surgery Partners' public shareholders and whether Surgery Partners' Board adequately protected shareholder interests in negotiating and approving the transaction.”
SGRY SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES SURGERY PARTNERS, INC. PR Newswire
SGRY shareholders will receive just $23.50 per share in an all-cash transaction valued at approximately $5.7 billion in enterprise value; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers
Get started
Create a free account to read the full story.